Nexo Therapeutics
Aidan Finley is an accomplished business development professional with extensive experience in the biopharmaceutical sector. Currently a BD Consultant at Nexo Therapeutics since January 2025, Aidan previously held the position of Vice President of Business Development & Alliance Management at HOOKIPA Pharma Inc., overseeing alliances with Gilead and negotiable agreements with Qiagen. Aidan's notable achievements at Epizyme include leading its acquisition by Ipsen and negotiating significant collaborations in oncology. Aidan also has a strong background in strategy and market assessment, having worked with Health Advances and Massachusetts General Hospital prior to entering the biopharmaceutical industry. Aidan earned a Bachelor of Arts in Biology from Williams College.
This person is not in any teams
This person is not in any offices
Nexo Therapeutics
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.